Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease
Naga Chalasani, Eduardo Vilar‐Gómez, Rohit Loomba, et al.
Hepatology (2024) Vol. 80, Iss. 5, pp. 1212-1226
Closed Access | Times Cited: 11

Showing 11 citing articles:

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials
Javier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 2
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Disparities in Health Care in Patients With Chronic Liver Disease
Maryam Zafer, Ryan Tang, Marı́a Elena Martı́nez, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Rurality and neighborhood socioeconomic status are associated with overall and cause-specific mortality and hepatic decompensation in type 2 diabetes
Vincent Chen, Nicholas R. Tedesco, Jingyi Hu, et al.
The American Journal of Medicine (2025)
Closed Access
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Integrating PNPLA3 into clinical risk prediction
Vincent Chen, Umberto Vespasiani‐Gentilucci
Liver International (2024)
Open Access | Times Cited: 3
PNPLA3 rs738409, environmental factors and liver-related mortality in the U.S. Population
Eduardo Vilar‐Gómez, Samer Gawrieh, Raj Vuppalanchi, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 2
PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease
Elizabeth K. Speliotes, Carolin V. Schneider
Liver International (2024)
Closed Access | Times Cited: 2
Current Status of Genetics and Polygenic Risk Scores in Metabolic Dysfunction-Associated Steatohepatitis.
Naga Chalasani
PubMed (2024) Vol. 20, Iss. 8, pp. 460-503
Closed Access
Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos‐Molina
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
PNPLA3 as a driver of steatotic liver disease: navigating from pathobiology to the clinics via epidemiology
Ralf Weiskirchen, Amedeo Lonardo
Journal of Translational Genetics and Genomics (2024) Vol. 8, Iss. 4, pp. 355-77
Open Access
Page 1

Scroll to top